Pennsylvania Bio Issues Patient Impact Report on Vaccines

More than 330 vaccines in development or on the market to prevent life-threatening diseases

WAYNE, Pa.--()--Pennsylvania Bio (www.pennsylvaniabio.org) today issued an updated report on vaccines that details research happening through Pennsylvania companies to develop new vaccinations to combat disease and improve global health. This report is the latest in the Pennsylvania Bio MedTRACK Patient Impact Report series.

The report features information on 95 vaccines in development or awaiting approval and 239 marketed products from nine Pennsylvania companies. Companies with operations in Pennsylvania are working on vaccines for 46 diseases including Alzheimer’s disease, brain cancer, cervical cancer, HIV/AIDS, and influenza vaccinations.

“Pennsylvania has had a long history of innovation in vaccine development and disease eradication through vaccination,” said Christopher Molineaux, president of Pennsylvania Bio. “Immunizations save more than 3 million lives each year, and Pennsylvania’s bioscience industry is leading the way in vaccine innovation. The investments made by Pennsylvania’s bioscience industry are critical to public health and we are proud of their commitment to patients worldwide.”

The data for the Patient Impact Reports was compiled using the Pennsylvania Bio MedTRACK Database. While not all of the research captured in the report is happening within the borders of the Commonwealth of Pennsylvania, it is being conducted through companies that have significant operations in the commonwealth.

Other reports in the Pennsylvania Bio MedTRACK Patient Impact Report series may be downloaded from the Media Center section of www.pennsylvaniabio.org.

About Pennsylvania Bio

Pennsylvania Bio is ensuring Pennsylvania is the global leader in the biosciences by creating a cohesive statewide community that unites our biotechnology, medical device, diagnostic, pharmaceutical, research, and financial strengths. For more information, please visit www.pennsylvaniabio.org.

About the Pennsylvania Bio MedTRACK Database

Pennsylvania Bio has partnered with Life Science Analytics to provide its members access to the Pennsylvania Bio MedTRACK Database. This database provides comprehensive information on public and private bioscience companies in Pennsylvania through a proven corporate intelligence tool. Members of the media may request access to this database by emailing Amber van Niekerk at amber@pennsylvaniabio.org.

Contacts

Pennsylvania Bio
Media Contact
Amber van Niekerk
Office: 610.947.6800 ext. 211
Cell: 215.520.5035
amber@pennsylvaniabio.org

Contacts

Pennsylvania Bio
Media Contact
Amber van Niekerk
Office: 610.947.6800 ext. 211
Cell: 215.520.5035
amber@pennsylvaniabio.org